| Eukaryotic Virus Display: Engineering the Major Surface Glycoprotein of the Autographa californica Nuclear Polyhedrosis Virus (AcNPV) for the Presentation of … Y Boublik, PD Bonito, IM Jones Bio/technology 13 (10), 1079-1084, 1995 | 259 | 1995 |
| In vivo antitumor effect of an intracellular single‐chain antibody fragment against the E7 oncoprotein of human papillomavirus 16 L Accardi, F Paolini, A Mandarino, Z Percario, P Di Bonito, V Di Carlo, ... International journal of cancer 134 (11), 2742-2747, 2014 | 191 | 2014 |
| Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection R Franconi, P Di Bonito, F Dibello, L Accardi, A Muller, A Cirilli, ... Cancer Research 62 (13), 3654-3658, 2002 | 139 | 2002 |
| Survivin as a marker of cervical intraepithelial neoplasia and high-risk human papillomavirus and a predictor of virus clearance and prognosis in cervical cancer M Branca, C Giorgi, D Santini, L Di Bonito, M Ciotti, S Costa, A Benedetto, ... American journal of clinical pathology 124 (1), 113-121, 2005 | 130 | 2005 |
| Up-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia … M Branca, M Ciotti, C Giorgi, D Santini, L Di Bonito, S Costa, A Benedetto, ... European Journal of Obstetrics & Gynecology and Reproductive Biology 130 (2 …, 2007 | 75 | 2007 |
| Aberrant expression of VEGF-C is related to grade of cervical intraepithelial neoplasia (CIN) and high risk HPV, but does not predict virus clearance after treatment of CIN or … M Branca, C Giorgi, D Santini, L Di Bonito, M Ciotti, A Benedetto, P Paba, ... Journal of clinical pathology 59 (1), 40-47, 2006 | 67 | 2006 |
| Matrix metalloproteinase-2 (MMP-2) and its tissue inhibitor (TIMP-2) are prognostic factors in cervical cancer, related to invasive disease but not to high-risk human … M Branca, M Ciotti, C Giorgi, D Santini, L DI BONITO, S Costa, ... Anticancer research 26 (2B), 1543-1556, 2006 | 66 | 2006 |
| Exploiting the plant secretory pathway to improve the anticancer activity of a plant-derived HPV16 E7 vaccine R Franconi, S Massa, E Illiano, A Muller, A Cirilli, L Accardd, PDI Bonito, ... International journal of immunopathology and pharmacology 19 (1 …, 2006 | 65 | 2006 |
| Antitumor HPV E7-specific CTL activity elicited by in vivo engineered exosomes produced through DNA inoculation P Di Bonito, C Chiozzini, C Arenaccio, S Anticoli, F Manfredi, E Olivetta, ... International journal of nanomedicine, 4579-4591, 2017 | 63 | 2017 |
| Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteins P Di Bonito, F Grasso, S Mochi, L Accardi, MG Donà, M Branca, S Costa, ... Infectious agents and cancer 1, 1-9, 2006 | 58 | 2006 |
| Toscana virus genomic L segment: molecular cloning, coding strategy and amino acid sequence in comparison with other negative strand RNA viruses L Accardi, MC Grò, P Di Bonito, C Giorgi Virus research 27 (2), 119-131, 1993 | 57 | 1993 |
| HPV-E7 Delivered by Engineered Exosomes Elicits a Protective CD8+ T Cell-Mediated Immune Response P Di Bonito, B Ridolfi, S Columba-Cabezas, A Giovannelli, C Chiozzini, ... Viruses 7 (3), 1079-1099, 2015 | 56 | 2015 |
| Anti-tumor CD8+ T cell immunity elicited by HIV-1-based virus-like particles incorporating HPV-16 E7 protein P Di Bonito, F Grasso, S Mochi, L Petrone, E Fanales-Belasio, A Mei, ... Virology 395 (1), 45-55, 2009 | 55 | 2009 |
| Upregulation of telomerase (hTERT) is related to the grade of cervical intraepithelial neoplasia, but is not an independent predictor of high‐risk human papillomavirus, virus … M Branca, C Giorgi, M Ciotti, D Santini, L Di Bonito, S Costa, A Benedetto, ... Diagnostic cytopathology 34 (11), 739-748, 2006 | 55 | 2006 |
| Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in … M Branca, M Ciotti, C Giorgi, D Santini, L Di Bonito, S Costa, A Benedetto, ... International journal of gynecological pathology 27 (2), 265-273, 2008 | 52 | 2008 |
| Oncogenic papillomavirus and polyomavirus in water environments: is there a potential for waterborne transmission? M Fratini, P Di Bonito, G La Rosa Food and environmental virology 6, 1-12, 2014 | 50 | 2014 |
| Antibodies in single-chain format against tumour-associated antigens: present and future applications L Accardi, P Di Bonito Current medicinal chemistry 17 (17), 1730-1755, 2010 | 49 | 2010 |
| Activity of Toscana and Rift Valley fever virus transcription complexes on heterologous templates L Accardi, C Prehaud, P Di Bonito, S Mochi, M Bouloy, C Giorgi Journal of General Virology 82 (4), 781-785, 2001 | 48 | 2001 |
| Antigen production in plant to tackle infectious diseases flare up: the case of SARS OC Demurtas, S Massa, E Illiano, D De Martinis, PKS Chan, P Di Bonito, ... Frontiers in plant science 7, 164284, 2016 | 47 | 2016 |
| Down-regulation of E-cadherin is closely associated with progression of cervical intraepithelial neoplasia (CIN), but not with high-risk human papillomavirus (HPV) or disease … M Branca, C Giorgi, M Ciotti, D Santini, L Di Bonito, S Costa, A Benedetto, ... Eur. J. Gynaec. Oncol.-IssN 392, 2936, 2006 | 46 | 2006 |
Antonio CassonePolo della genomica, genetica e biologiaVerified email at pologgb.com
